Periodic paralysis is an ion channel disorder of skeletal muscle wherein recurrent episodes of severe weakness are caused by anomalous depolarization of the resting potential, that persists for minutes to hours, with associated inactivation of voltage-gated sodium channels and loss of fiber excitability (Cannon, 2015). Clinical management of periodic paralysis is symptomatic; that is to say, it minimizes provocative maneuvers that trigger attacks of weakness or use interventions that may reduce attack frequency and severity (Statland et al., 2018). Administration of calcium gluconate has been used empirically in an attempt to hasten recovery from an ongoing attack of weakness (Lehmann-Horn et al., 2004), and in this issue of the Journal of General Physiology,Uwera et al (2020) use a mouse model of hyperkalemic periodic paralysis (HyperKPP; Hayward et al., 2008) to systematically assess the efficacy of Ca2+ in reducing the susceptibility to high-K+ induced loss of force and explore the mechanistic basis for protection.
The empirical use of calcium gluconate as abortive therapy for an episode of HyperKPP dates back to the 1950s (Gamstorp, 1956), before it was known that this dominantly inherited disorder is caused by gain-of-function missense mutations in the skeletal muscle isoform of the α subunit of the voltage-gated sodium channel, NaV1.4 (Cannon, 2015; Lehmann-Horn et al., 2004). Controlled trials on the effectiveness of Ca2+ in HyperKPP have never been performed, and anecdotal reports describe mixed results (reviewed in Samaha, 1965), although there is one convincing example wherein low serum total Ca2+ (<2.1 mM; normal 2.1–2.6) and Mg2+ (<0.5 mM, normal 0.6–1.1 mM) secondary to chemotherapy dramatically worsened the symptoms of HyperKPP (Mankodi et al., 2015). To address the question of a role for extracellular Ca2+ in modulating susceptibility to weakness in HyperKPP, Uwera et al (2020) performed ex vivo contraction studies and microelectrode measurements of in an established mouse model for HyperKPP (NaV1.4-M1592V knock-in; Hayward et al., 2008).
This study convincingly demonstrates that reducing Ca2+ aggravates the susceptibility to high-K+ induced loss of force in HyperKPP muscle. The force– relation has a midpoint (50% loss) of ∼11–12 mM for HyperKPP muscle in 2.4 mM Ca2+, and this shifted leftward to ∼8 mM in 1.3 mM Ca2+. Moreover, the tetanic force decreased to 20–30% of baseline in 0.3 mM Ca2+, even while K+ remained at a control level of 4.7 mM (e.g., Fig. 1 in Uwera et al., 2020). In contrast, WT muscle tolerates a 12 mM K+ challenge in 2.4 mM Ca2+ (∼75% of baseline force). At the lowest concentration of Ca2+ tested (0.3 mM), WT muscle also had a pronounced loss of force during a high-K challenge (e.g., 50% reduction in 10 mM K+). These observations led the authors to propose several mechanisms that may contribute to enhanced K+-sensitivity in low Ca2+: (1) the gating of voltage-dependent channels will have an apparent left (hyperpolarized) shift caused by the reduced screening of negative surface charge on the external face of the plasma membrane in low divalent cation solutions (Hille, 1968); (2) impaired Ca2+ release, which is an intrinsic dependence of excitation–contraction on extracellular Ca2+ that is not alleviated by substitution with Mg2+ (Brum et al., 1988); and (3) enhanced depolarization of The latter is more complex than appears at first glance because it includes possible contributions from (i) a depolarized shift of the equilibrium potential for K+; (ii) a hyperpolarized shift of NaV1.4 activation in low divalent cation solutions; and (iii) for HyperKPP fibers gain-of-function defects manifest as impaired inactivation and a hyperpolarized shift of activation. Taken together, it is proposed these effects cause a depolarization-dependent loss of force in low Ca2+ that occurs in WT fibers only in when K+ is increased (e.g., 10 mM), but happens in HyperKPP fibers even in normal K+ because the NaV1.4 gain-of-function defect increases the propensity for depolarization.
An indirect method was used to assess whether the variations of extracellular Ca2+ used in the contractility studies caused a shift in the voltage-dependence of sodium channel availability. The peak amplitude of the Na+ current was estimated from the maximum during the upstroke of the action potential (AP; Hodgkin and Katz, 1949). The limitations of using this approach to determine the voltage-dependence of availability are well known: (i) is proportional to the total sum of ionic currents and therefore is representative of only when the relative contribution of other currents is much smaller, as normally occurs during the maximum rate of rise for normal APs, but less so for attenuated APs; and (ii) changes in are used to vary but precise control is not possible and so binning of data over a range of is required for the analysis. Even with these caveats, the authors show for WT muscle that reducing extracellular Ca2+ from 2.4 to 0.3 mM (with constant Mg2+ of 3.1 mM) caused a 5 mV leftward shift of Na+ channel availability (visually estimated from Fig. 14 A in Uwera et al. (2020)). This shift was prevented by maintaining a constant divalent concentration (2.4 mM Ca2+ + 3.1 mM Mg2+ 0.3 mM Ca2+ + 5.2 mM Mg2+), consistent with the expectation of a negative surface charge effect. For HyperKPP muscle (NaV1.4-M1592V), the technique revealed the previously reported impairment of slow inactivation (Hayward et al., 1997), such that in 2.4 mM Ca2+ availability was barely reduced even for the largest test depolarization of mV. Again, in support of a surface charge effect, a large decrease in availability was observed in 0.3 mM Ca2+, consistent with a left shift of gating, and which was also reversed by increased Mg2+.
The relation between low Ca2+ and depolarization of follows the same trend observed for low Ca2+ and the loss of contractility. Namely, for WT fibers in 4.7 mM K+, a reduction of Ca2+ from 2.4 to 0.3 mM did not cause depolarization or a loss of force. Only when external K+ was increased to 10 mM did WT fibers have an additional loss of force and depolarization in response to reducing Ca2+. Conversely, HyperKPP muscle always depolarized and had lower tetanic force in response to a reduction of Ca2+ (2.4 mM 0.3 mM), regardless of whether external K+ was 4.7 or 10 mM. This pattern is qualitatively consistent with their proposed mechanism for loss of contractility in low Ca2+, wherein depolarization (from high K+ or from the HyperKPP mutation) is necessary to exhibit the Ca2+ sensitivity. It would be interesting to test whether the depolarization induced by low Ca2+ would be prevented if the total divalent concentration were held constant. These data might provide additional insight on whether the left shift of gating contributes to depolarization, perhaps by enhancing a small subthreshold Na+ current.
The major finding of this study, that low Ca2+ clearly exacerbates the K+-induced loss of force in HyperKPP, has important translational value to the management of this muscle channelopathy. The robust demonstration of the deleterious effect of low Ca2+ would have been impractical to establish in clinical studies or with human biopsy material, which demonstrates the power of high-fidelity mouse models of human disease. Another important point is that both WT and HyperKPP muscle show this Ca2+ sensitivity in the proper context. As the authors point out, this implies the exacerbation of weakness for HyperKPP in low Ca2+ is not because of a specific mechanism imparted by the NaV1.4 mutation. Instead, the loss of force in low Ca2+ is a fundamental property of skeletal muscle under conditions where is depolarized.
Eduardo Ríos served as editor.
This work was supported by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (R01-AR063182).
The author declares no competing financial interests.